Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis C?

Journal of Clinical Psychiatry

Volumn 75, Issue 10, 2014, Pages e1122-e1126

  Pocha, Christine ^a   Knott, Astrid ^a   Rector, Thomas S ^a   Dieperink, Eric ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; NEFAZODONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; FOLLOW UP; GOVERNMENT; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; CARCINOMA, HEPATOCELLULAR; CHEMICALLY INDUCED; EPIDEMIOLOGY; HEPATITIS C, CHRONIC; LIVER NEOPLASMS; MIDDLE AGED; REGISTER; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; CARCINOMA, HEPATOCELLULAR; DRUG PRESCRIPTIONS; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; REGISTRIES; SEROTONIN UPTAKE INHIBITORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 84922391701     PISSN: 01606689     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.13m08877     Document Type: Article

References (21)

1. Caldwell S, Park SH. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol. 2009;44(suppl 19):96-101. doi:10.107/s0535-08-258-6 PubMed
2. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264-1273.e1. doi:10.1053/j.gastro.201.12.061 PubMed
3. Zhang YJ, Chen Y, Ahsan H, et al. Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma. Cancer Lett. 2005;221(2): 135-143. doi:10.1016/j.canlet.204.08.028 PubMed
4. Sulaiman P, Joseph B, Kaimal SB, et al. Decreased hepatic 5-HT1A receptors during liver regeneration and neoplasia in rats. Neurochem Res. 2008;33(3):444-449. doi:10.107/s1064-07-9452-4 PubMed
5. Lesurtel M, Soll C, Graf R, et al. Role of serotonin in the hepatogastroIntestinal tract: an old molecule for new perspectives. Cell Mol Life Sci. 2008;65(6):940-952. doi:10.107/s018-07-737-3 PubMed
6. Lesurtel M, Soll C, Humar B, et al. Serotonin: a double-edged sword for the liver? Surgeon. 2012;10(2):107-113. doi:10.1016/j.surge.201.1.02 PubMed
7. Liang C, Chen W, Zhi X, et al. Serotonin promotes the proliferation of serumdeprived hepatocellular carcinoma cells via upregulation of FOXO3a. Mol Cancer. 2013;12(1):14. doi:10.186/1476-4598-12-14 PubMed
8. Soll C, Jang JH, Riener MO, et al. Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology. 2010;51(4):1244-1254. doi:10.102/hep.2341 PubMed
9. Ruddell RG, Oakley F, Hussain Z, et al. A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am J Pathol. 2006;169(3):861-876. doi:10.2353/ajpath.206.050767 PubMed
10. Ebrahimkhani MR, Oakley F, Murphy LB, et al. Stimulating healthy tissue regeneration by targeting the 5-HTB receptor in chronic liver disease. Nat Med. 2011;17(12):1668-1673. doi:10.1038/nm.2490 PubMed
11. Nocito A, Dahm F, Jochum W, et al. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Gastroenterology. 2007;133(2):608-618. doi:10.1053/j.gastro.207.05.019 PubMed
12. el-Serag HB, Kunik M, Richardson P, et al. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002;123(2):476-482. doi:10.1053/gast.202.34750 PubMed
13. Nelligan JA, Loftis JM, Matthews AM, et al. Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart review. J Clin Psychiatry. 2008;69(5):810-816. doi:10.408/JCP.v69n0514 PubMed
14. Bianchi G, Marchesini G, Nicolino F, et al. Psychological status and depression in patients with liver cirrhosis. Dig Liver Dis. 2005;37(8):593-600. doi:10.1016/j.dld.205.01.020 PubMed
15. Veterans Health Administration, Department of Veterans Affairs. Directive 2011-026: Clinical case registry (ccr) software: maintenance and clinical staff Support. http://www.va.gov/vhapublications/ViewPublication.asp?pub-ID=2420. Updated June 23, 2011. Accessed April 2, 2014.
16. Singer JD, Willett JB. Extending the Cox Regression Model. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York, NY: Oxford Elsevier Press; 2003:543-606. doi:10.1093/acprof:oso/9780195152968.03.015
17. Fulton-Kehoe D, Rossing MA, Rutter C, et al. Use of antidepressant medications in relation to the incidence of breast cancer. Br J Cancer. 2006;94(7):1071-1078. doi:10.1038/sj.bjc.603017 PubMed
18. Coogan PF, Strom BL, Rosenberg L. Antidepressant use and colorectal cancer risk. Pharmacoepidemiol Drug Saf. 2009;18(11):1111-1114. doi:10.102/pds.1808 PubMed
19. Eom CS, Park SM, Cho KH. Use of antidepressants and the risk of breast cancer: a meta-analysis. Breast Cancer Res Treat. 2012;136(3):635-645. doi:10.107/s10549-012-2307-y PubMed
20. Friedman GD, Udaltsova N, Chan J, et al. Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened. Cancer Causes Control. 2009;20(10):1821-1835. doi:10.107/s1052-09-9375-2 PubMed
21. Davila JA, Henderson L, Kramer JR, et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med. 2011;154(2):85-93. doi:10.7326